🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/06/2017 63,23 63,23 62,54 62,54 -0,58% 1,10% 8.511.437
26/06/2017 63,12 63,36 62,81 62,90 -0,36% 0,86% 7.940.067
23/06/2017 63,02 63,35 62,82 63,13 +0,21% 0,83% 14.769.988
22/06/2017 62,51 63,33 62,39 63,00 +0,86% 1,51% 14.087.111
21/06/2017 61,60 62,60 61,60 62,46 +1,44% 1,61% 11.679.960
20/06/2017 60,76 61,98 60,67 61,57 +1,33% 2,17% 10.755.624
19/06/2017 60,20 60,89 60,13 60,76 +1,13% 1,25% 8.831.391
16/06/2017 60,36 60,79 59,82 60,09 -0,35% 1,61% 15.617.296
15/06/2017 60,40 60,53 60,00 60,30 -0,28% 0,88% 8.244.406
14/06/2017 60,13 60,73 60,13 60,47 +0,16% 0,98% 10.834.853
13/06/2017 60,81 60,92 60,14 60,37 -1,74% 1,27% 12.631.544
12/06/2017 61,44 61,72 61,26 61,44 +0,00% 0,75% 9.851.514
09/06/2017 60,31 61,49 60,25 61,44 +1,88% 2,06% 11.266.419
08/06/2017 61,13 61,31 59,95 60,31 -1,34% 2,22% 19.411.056
07/06/2017 61,64 61,69 61,07 61,13 -0,94% 1,01% 7.971.717
06/06/2017 62,02 62,06 61,51 61,71 -0,61% 0,89% 8.218.206
05/06/2017 62,36 62,40 61,74 62,09 -0,61% 1,06% 6.254.988
02/06/2017 62,46 62,58 62,19 62,47 +0,32% 0,61% 6.600.933
01/06/2017 62,11 62,27 61,89 62,27 +0,23% 0,61% 7.923.404
31/05/2017 62,10 62,49 62,05 62,13 +0,35% 0,71% 8.162.138
30/05/2017 61,76 62,16 61,57 61,91 -0,06% 0,94% 5.120.109
26/05/2017 62,02 62,22 61,85 61,95 -0,18% 0,60% 3.862.614
25/05/2017 61,98 62,14 61,70 62,06 +0,17% 0,71% 7.436.503
24/05/2017 61,80 62,21 61,58 61,96 +0,59% 1,02% 7.289.259
23/05/2017 61,07 61,63 61,07 61,59 +0,80% 0,92% 6.009.861
22/05/2017 60,78 61,49 60,66 61,11 +0,41% 1,37% 6.525.372
19/05/2017 61,11 61,11 60,59 60,86 -0,17% 0,84% 9.739.798
18/05/2017 60,03 61,55 60,03 60,96 +1,41% 2,53% 12.528.316
17/05/2017 60,87 60,87 60,00 60,11 -1,24% 1,43% 8.296.911
16/05/2017 60,53 60,94 60,25 60,87 +0,44% 1,15% 8.248.494